Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Fish Forum Fish at the Podium

Life Sciences Intellectual Property Summit

Wednesday, May 15th, 2013

Fish Forum Fish at the Podium

Life Sciences Intellectual Property Summit

Wednesday, May 15th, 2013

Back to Events Listing
FR_life_sciences_banner_5003.jpg
Life Sciences Intellectual Property Summit
Princeton Marriott Hotel & Conference Center at Forrestal
Princeton, NJ

Wednesday, May 15, 2013
11:30 am – 12:00 noon Registration
12:00 noon – 12:30 pm Lunch
12:30 pm – 1:30 pm Judges Roundtable
1:30 pm – 5:00 pm Panels and Networking Breaks
5:00 pm – 6:30 pm Reception

MSMC-gray3.gif

Judges Roundtable
The Honorable Garrett Brown, Jr. (Ret.), US District Court for the District of New Jersey
The Honorable John C. Lifland (Ret.), US District Court for the District of New Jersey
The Honorable Gregory M. Sleet, Chief District Judge, District of Delaware

Moderator: William Marsden, Fish & Richardson

Panel Topics
Following the Judges Roundtable, we will have a series of in-house counsel panels led by principals from Fish & Richardson’s life sciences practice.
Patent-Eligible Subject Matter
This panel will consist of two attorneys from the Mayo v. Prometheus Supreme Court victory (one from Mayo and one from Fish), an attorney from PerkinElmer involved in the 2012 PerkinElmer v. Intema Federal Circuit victory, and a Fish biotech patent prosecutor with over 20 years of experience. They will debate various thorny Section 101 issues and strategies for dealing with them, including approaches to claiming diagnostic and personalized medicine methods likely to satisfy both the USPTO and the courts.

Completing your IP Arsenal with Trade Secrets
Trade secrets and trademarks should be utilized to compliment your patent portfolio and provide fuller and more complete protection to your intellectual property. Learn more about key issues to consider in these areas.

Pharmaceutical Litigation/Safe Harbor
Panelists will discuss the new reach of the safe harbor statute in light of the Federal Circuit decisions in Classen and Momenta – what these decisions mean for post-market reporting by brand and generic drug manufacturers, and what it could mean for brand biologic manufacturers about to confront biosimilar entry.


Fish & Richardson will apply for up to 2.5 hours of CLE credit in most states.

Participation reserved for clients and guests by invitation only. For more information contact Emma Brown at ebrown@fr.com

 

 

 

Stay current with Fish Sign up for our Newsletter